| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
National Research Corp (NRC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. NRC is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 172.0K | $3.19M | - | |
| COO | 140.5K | $2.61M | - | |
| VP | 100.0K | $1.85M | - | |
| Dir | 22.6K | $419.5K | - | |
| Dir | 22.6K | $419.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2017 | Nunnelly John N | Director | Sale+OE | 4,640 | $27.98 | $129,819.92 | -7.5% | |
| Feb 17, 2017 | Hays Michael D. | CEO | Sell | 500,000 | $17.45 | $8,725,000.00 | -8.7% | |
| Jan 17, 2017 | Hays Michael D. | CEO | Sell | 14,296 | $18.48 | $264,201.58 | -0.1% | |
| Jan 11, 2017 | Hays Michael D. | CEO | Sell | 700 | $19.00 | $13,300.00 | - | |
| Jan 10, 2017 | Hays Michael D. | CEO | Sell | 5,482 | $19.24 | $105,466.51 | - | |
| Nov 30, 2016 | Hays Michael D. | CEO | Sell | 87,010 | $16.00 | $1,392,160.00 | -0.5% | |
| Nov 28, 2016 | Hays Michael D. | CEO | Sell | 13,085 | $16.00 | $209,360.00 | - | |
| Nov 22, 2016 | Hays Michael D. | CEO | Sell | 28,009 | $16.02 | $448,628.61 | -0.1% | |
| Nov 17, 2016 | Hays Michael D. | CEO | Sell | 24,834 | $16.01 | $397,686.79 | -0.1% | |
| Nov 14, 2016 | Hays Michael D. | CEO | Sell | 18,728 | $16.04 | $300,352.70 | -0.1% |